The majority of patients with pulmonary arterial hypertension, except for a few special circumstances, will begin treatment on combination therapy, instead of monotherapy, because combination therapy has been shown in trials to ahve better outcomes, explained Simon Gibbs, MD, Reader in Pulmonary Hypertension at the National Heart and Lung Institute, Imperial College London.
The majority of patients with pulmonary arterial hypertension, except for a few special circumstances, will begin treatment on combination therapy, instead of monotherapy, because combination therapy has been shown in trials to ahve better outcomes, explained Simon Gibbs, MD, Reader in Pulmonary Hypertension at the National Heart and Lung Institute, Imperial College London.
Transcript
How do you weigh the benefits of monotherapy versus combination therapy in patients with pulmonary hypertension?
I think nowadays, I wouldn't normally, I would no longer start monotherapy. I would start with combination therapy in pulmonary arterial hypertension, except in very special circumstances, such as you have a responder to nitric oxide—a vasoreactivity test, in other words—and they would go onto long-term treatment with calcium channel blockers. And there are a few other circumstances. Perhaps patients with portal hypertension or pulmonary veno-occlusive disease, one would use monotherapy.
But in the vast majority of patients with pulmonary arterial hypertension, I would use initial combination therapy, because it has been shown in clinical trials of initial combination that the outcomes are better and in sequential combination that the outcomes are better too. There are a small group of patients who've been on monotherapy for 5 or 10 years, and they're completely stable. And I wouldn't go around changing them at all. But the majority of patients now are going to be on combination therapy, if not initially, very quickly.
Certain genes have been linked to significant weight reduction in obesity treatment; research boosts plaintiffs’ cases against Johnson & Johnson for their talc-based baby powder; proposed legislation aims to address concerns following Alabama Supreme Court ruling on embryos.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
As AI Utilization Advances in Health Care, Experts at ATS 2024 Share Insights
May 20th 2024Fatima Rodriguez, MD, MPH, from Stanford University, and Matthew DeCamp, MD, PhD, from the University of Colorado, joined Michael Howell, MD, MPH, of Google, on the stage at ATS 2024 to discuss artificial intelligence (AI) in health care.
Read More
Enhancing Outpatient Hemophilia Care May Improve Health Outcomes and Costs
May 18th 2024Prospective data from patients attending a rural practice in West Virginia between 2016 and 2023 show that a quality improvement program that followed guideline recommendations and was tailored to specific patient needs reduced preventable bleeds and lowered costs.
Read More